This English-taught Master's programme builds advanced expertise in pharmacoeconomics, health economics, health products and market access, combining academic theory with applied practice in an international setting. You will deepen methodological and strategic skills needed to operate in global health markets, with particular emphasis on how pharmaceuticals and medical devices reach and are paid for by healthcare systems.
The curriculum focuses on core topics such as market access, pricing and reimbursement, ethical resource allocation and market strategies for both pharmaceutical and medical-technology sectors. The programme gives you the analytical tools and practical approaches to address challenges in pharmaceutical and medical technology fields and to compare alternative strategies from the viewpoints of healthcare systems and commercial organisations. Teaching takes place in a multicultural environment and includes a 12-week residency placement in Germany or abroad to gain hands-on experience.
Graduates are prepared for a variety of professional roles — for example, in regulatory affairs, international pricing policy, health economics or as market access managers.
(For detailed admission criteria, application deadlines and tuition information please consult the university’s official programme page.)
This two-year Master’s programme is internationally recognised in the pharmaceutical and healthcare sectors and is particularly attractive for natural scientists seeking to change career direction. With about 75% of students coming from abroad, the cohort is highly international, giving you frequent cross-cultural exchange and exposure to a wide range of healthcare systems. The curriculum is interdisciplinary and geared toward applied, career-oriented training that prepares graduates for senior roles in public authorities, research institutes, and industry.
A strong practical emphasis is built into the course: the third semester is dedicated to a six-month in-company placement, and roughly 80% of students go on to write their Master’s thesis at the placement site—many of whom are then hired as salaried employees. Teaching focuses on economic analysis of healthcare and pharmaceuticals, including statistics and cost–benefit methods, so you learn to evaluate industry processes and to translate economic evidence into policy and business decisions.
You will gain the technical tools and sector knowledge needed to work on licensing, pricing and market access of drugs and medical devices, and to operate within international health technology assessment (HTA) and reimbursement environments. The programme also covers ethical and policy dimensions of resource allocation, enabling you to assess how healthcare systems are funded and regulated across different cultural and political settings.
Key modules
Learning outcomes
Programme structure highlights
Admission requirements
You must hold a completed undergraduate degree (Bachelor’s, honours, or an equivalent qualification) corresponding to at least 180 ECTS credits. Eligible fields of study include health and life sciences, economics, or natural sciences — for example: pharmacy, chemistry, biology, medical technology, medical engineering, or nutrition.
If your bachelor’s degree is in a different subject area, you can still qualify if you have practical industry experience: a minimum of six months’ professional work in the pharmaceutical industry or the healthcare sector is required. International applicants whose degree systems do not use ECTS should be prepared to demonstrate that their qualification is comparable to a 180 ECTS bachelor-level degree.
Required documents and evidence are typically expected to show your academic credentials and, where applicable, employment history (e.g., employer letters or contracts) to confirm the required professional experience.
Winter Semester (International)
Applications are possible all year round.
Graduates are prepared for roles in regulatory affairs, health economics, international pricing policy, market access management, and related functions in pharmaceutical and medical device companies, consultancies, public authorities, HTA agencies, and research institutes. The programme’s methodological training in economic evaluation, modelling and statistics also enables positions in health-technology assessment and pharmacoeconomic research.
The obligatory industry residency and strong industry links increase employability: many students complete their master’s thesis at host organisations and are subsequently offered salaried positions. Employers typically value graduates for their combined understanding of healthcare systems, pricing and reimbursement, and strategic market-access skills.